268 related articles for article (PubMed ID: 11797783)
1. Current status of flavivirus vaccines.
Barrett AD
Ann N Y Acad Sci; 2001 Dec; 951():262-71. PubMed ID: 11797783
[TBL] [Abstract][Full Text] [Related]
2. Flaviviruses and flavivirus vaccines.
Heinz FX; Stiasny K
Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
[TBL] [Abstract][Full Text] [Related]
3. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
Lai CJ; Monath TP
Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
[TBL] [Abstract][Full Text] [Related]
4. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
Ishikawa T; Yamanaka A; Konishi E
Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
[TBL] [Abstract][Full Text] [Related]
5. New developments in flavivirus vaccines with special attention to yellow fever.
Pugachev KV; Guirakhoo F; Monath TP
Curr Opin Infect Dis; 2005 Oct; 18(5):387-94. PubMed ID: 16148524
[TBL] [Abstract][Full Text] [Related]
6. Traditional and novel approaches to flavivirus vaccines.
Pugachev KV; Guirakhoo F; Trent DW; Monath TP
Int J Parasitol; 2003 May; 33(5-6):567-82. PubMed ID: 12782056
[TBL] [Abstract][Full Text] [Related]
7. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
[TBL] [Abstract][Full Text] [Related]
8. Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.
Eckels KH; Putnak R
Adv Virus Res; 2003; 61():395-418. PubMed ID: 14714438
[TBL] [Abstract][Full Text] [Related]
9. The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines.
Bonaldo MC; Caufour PS; Freire MS; Galler R
Mem Inst Oswaldo Cruz; 2000; 95 Suppl 1():215-23. PubMed ID: 11142718
[TBL] [Abstract][Full Text] [Related]
10. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
[TBL] [Abstract][Full Text] [Related]
11. Live flavivirus vaccines: reasons for caution.
Seligman SJ; Gould EA
Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
13. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
[TBL] [Abstract][Full Text] [Related]
14. Advances in flavivirus vaccine development.
Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
[TBL] [Abstract][Full Text] [Related]
15. A Perspective on Current Flavivirus Vaccine Development: A Brief Review.
Dutta SK; Langenburg T
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112840
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
[TBL] [Abstract][Full Text] [Related]
17. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial.
Sandberg JT; Löfling M; Varnaitė R; Emgård J; Al-Tawil N; Lindquist L; Gredmark-Russ S; Klingström J; Loré K; Blom K; Ljunggren HG
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010616. PubMed ID: 36758067
[TBL] [Abstract][Full Text] [Related]
19. Flavivirus vaccines.
Stephenson JR
Vaccine; 1988 Dec; 6(6):471-80. PubMed ID: 2854336
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of chimeric yellow fever 17D/dengue viral replication in ticks.
Kazimírová M; Mantel N; Raynaud S; Slovák M; Ustaniková K; Lang J; Guy B; Barban V; Labuda M
Vector Borne Zoonotic Dis; 2012 Nov; 12(11):979-85. PubMed ID: 22925017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
